Terms & Condition

This Document Is An Electronic Record In Terms of Applicable Law. This Electronic Record Is Generated By A Computer System And Does Not Require Any Physical Or Digital Signatures.

1.The domain name [www.erasavir.com], an internet based website, owned and operated by Palani LLC, an LLC duly incorporated under the laws of Pennsylvania in collaboration with Strassenburg Pharmaceuticals Limited, a company duly incorporated under the provisions of the Companies Act, 2013 (hereinafter, referred to as “Company” “Erasavir” or “We” or “Our” or “Us” or “Company”). The domain name is collectively referred to as “Website”. The Terms & Conditions is also applicable to the employees and consultants of the Company.

2.Your access or use of the Website, transaction on the Website and use of Services (as defined herein below) hosted or managed remotely through the Website, are governed by the following terms and conditions (hereinafter referred to as the Terms & Conditions”), including the applicable policies which are incorporated herein by way of reference. These Terms & Conditions constitutes a legal and binding contract between you (hereinafter referred to as “You” or “Your” or the “User”) on one part and Erasavir the other Part.

3.By accessing, browsing or in any way transacting on the Website, or availing any Services, You signify Your agreement to be bound by these Terms & Conditions.Further, by impliedly or expressly accepting these Terms & Conditions, you also accept and agree to be bound by Our policies, including the Privacy Policy (as set out in Part B herein below), and such other rules, guidelines, policies, terms and conditions as are relevant under the applicable law(s) in India and other jurisdictions as applicable to the Company for the purposes of accessing, browsing or transacting on the Website, or availing any of the Services, and such rules, guidelines, policies, terms and conditions shall be deemed to be incorporated into, and considered as part and parcel of these Terms & Conditions. However, if You navigate away from the Website to a third party website, You may be subject to alternative terms and conditions of use and privacy policy, as may be specified on such website. In such event, the terms and conditions of use and privacy policy applicable to that website will govern Your use of that website.

4.The Website is a platform that facilitates (i) online purchase of pharmaceutical products sold by the Company; (ii) online advertisements of various sponsors advertising and marketing their own good and services (“Third Party Advertisers”) (also referred to as the “Third Party Service Providers”). Further the Website also serves as an information platform providing health and wellness related information (“Information Services”) to the Users accessing the Website (The services of the Third Party Services Providers, sale of pharmaceutical products by the Company and the Information Services are collectively referred to as the “Services”).

5. The arrangement between the Third Party Service Providers, You and Us shall be governed in accordance with these Terms & Conditions. The Services would be made available to such natural persons who have agreed to use the Website after obtaining due registration, in accordance with the procedure as determined by Us, from time to time, (referred to as “You” or “Your” or “Yourself” or “User”, which terms shall also include natural persons who are accessing the Website merely as visitors). The Services are offered to You through various modes which shall include issue of discount coupons and vouchers that can be redeemed for various goods/ services offered for sale by relevant Third Party Service Providers. To facilitate the relation between You and the Third Party Service Providers through the Website, Erasavir shall send to You (promotional content including but not limited to emailers, notifications and messages).

6.You agree and acknowledge that the Website is a platform that You and Third Party Service Providers utilize to meet and interact with another for their transactions. Erasavir is not and cannot be a party to or save as except as may be provided in these Terms & Conditions, control in any manner, any transaction between You and the Third Party Service Providers.

7.Erasavir reserves the right to change or modify these Terms & Conditions or any policy or guideline of the Website including the Privacy Policy, at any time and in its sole discretion. Any changes or modifications will be effective immediately upon posting the revisions on the Website and You waive any right You may have to receive specific notice of such changes or modifications, provided however that, we will inform You of such changes at least once a year. Your continued use of the Website will confirm Your acceptance of such changes or modifications; therefore, You should frequently review these Terms & Conditions and applicable policies to understand the terms and conditions that apply to Your use of the Website.

8.As a condition to Your use of the Website, You must be 18 (eighteen) years of age or older to use or visit the Website in any manner. By visiting the Website or accepting these Terms & Conditions, You represent and warrant to Erasavir that You are 18 (eighteen) years of age or older, and that You have the right, authority and capacity to use the Website and agree to and abide by these Terms & Conditions.

9. These Terms & Conditions are published in compliance of applicable laws and jurisidctions therein.

10.Erasavir authorizes You to view and access the content available on the Website solely for the purposes of availing the Services, such as visiting, using, ordering, receiving, delivering and communicating only as per these Terms & Conditions. The contents on the Website including information, text, graphics, images, logos, button icons, software code, design, and the collection, arrangement and assembly of content, contains Third Party Service Providers’ content (“Third Party Content”) as well as in-house content provided by the Company including without limitation, text, copy, audio, video, photographs, illustrations, graphics and other visuals (“Company Content”) (collectively, “Content”). The Company Content is the property of the Company and is protected under copyright, trademark and other applicable law(s). You shall not modify the Company Content or reproduce, display, publicly perform, distribute, or otherwise use the Company Content in any way for any public or commercial purpose or for personal gain.

11.Compliance with these Terms & Conditions would entitle You to a personal, non-exclusive, non-transferable, limited privilege to access and transact on the Website.

12.These Terms & Conditions constitute an electronic record in terms of the IT Act and rules framed there under, as applicable and amended from time to time. This electronic record is generated by a computer system and does not require any physical or digital signatures.

ADVERTISING GUIDELINES FOR THE WEBSITE

13.As part of the Services provided by Us; We facilitate and allow Third Party Advertisers to place advertisements on the Website. Accordingly, there are guidelines (as listed herein below) which the Third Party Advertisers have to follow for placing such advertisements (the “Advertising Policy”).

a.For the Users: Erasavir clearly distinguishes between the editorial content and content that is created or provided by one of Our Third Party Advertisers. The advertisements will be labelled as & quot;sponsored", "from our Advertisers" or "advertisement". This content will not be reviewed by Our in- house editorial staff and shall not be subject to Our editorial policy (as set out herein below) but shall be subject to the Advertising Policy, these Terms & Conditions (except the editorial policy) and the Privacy Policy.

b.For the Third Party Advertisers: The Third Party Advertisers must be honest about the products or services their advertisements promote; the advertisement shall not create unrealistic expectation and must not be misleading or offending; must be responsible and of the highest standards and without compromising the consumer protection. The Advertising Policy applies to all the advertisements, listed or sought to be listed, on the Website.

c. General Rules: All the advertisements must comply with the Advertising Policy, the terms of these Terms & Conditions (except the editorial policy) and the Privacy Policy. Erasavir may, at any time and without having to serve any prior notice to the Third Party Advertisers, (i) upgrade, update, change, modify, or improve the Website or a part thereof in a manner it may deem fit, and (ii) change the content of the Advertising Policy and/ or these Terms & Conditions and/ or the Privacy Policy. It is the responsibility of the Third Party Advertisers, in such cases, to review the terms of the Advertising Policy and/ or these Terms & Conditions and/ or the Privacy Policy, from time to time. Such change shall be made applicable when they are posted. Erasavir may also alter or remove any content from the Website without notice and without liability. The Third Party Advertisers are also responsible for ensuring that their advertisements comply with all applicable law(s) in India and Pennsylvania and any other jurisdiction that such Third Party Advertiser(s) are based out of, industry codes, rules and regulations in each geographic area where the advertisements will run. All disclosures in the advertisements must be clear and conspicuous.

d.Review: All the advertisements are subject to the review and approval of Erasavir. Erasavir reserves the right to reject or remove any advertisement in its sole discretion for any reason. Further, Erasavir also reserves the right to request modifications to any advertisement, and to require factual substantiation for any claim made in an advertisement.

e. Prohibited Content: The advertisements must not infringe the intellectual property, privacy, publicity, copyright, or other legal rights of any person or entity. The advertisements must not be false, misleading, fraudulent, defamatory, or deceptive. The following advertisement content is prohibited:

(i) content that demeans, degrades, or shows hate toward a particular race, gender, culture, country, belief, or toward any member of a protected class;
(ii) content depicting nudity, sexual behaviour, or obscene gestures;
(iii) content depicting drug use;
(iv) content depicting excessive violence, including the harming of animals; shocking, sensational, or disrespectful content; deceptive, false or misleading content, including deceptive claims, offers, or business practices;
(v) content that directs users to phishing links, malware, or similarly harmful codes or sites; and
(vi) content that deceives the Users into providing personal information without their knowledge, under false pretences, or to companies that resell, trade, or otherwise misuse that personal information; and
(vii) content that violates any law for the time being in force.

f. Prohibited Advertisements: Advertisements for the following products and services are prohibited:

(i) adult products and services (other than contraceptives; see below);
(ii) cigarettes (including e-cigarettes), cigars, smokeless tobacco, and other tobacco products;
(iii) products or services that bypass copyright protection, such as software or cable signal descramblers;
(iv) products or services principally dedicated to selling counterfeit goods or engaging in copyright piracy; get-rich-quick or pyramid schemes or offers or any other deceptive or fraudulent offers;
(v) illegal or recreational drugs or drug paraphernalia;
(vi) counterfeit, fake or bootleg products, or replicas or imitations of designer products;
(vii) firearms, weapons, ammunition, or accessories;
(viii) advertisements that promote particular securities or that provide or allege to provide insider tips; any illegal conduct, product, or enterprise; unapproved pharmaceuticals and supplements; prescription drugs;
(ix) products that have been subject to any government or regulatory action or warning;
(x) products with names that are confusingly similar to an unapproved pharmaceutical or supplement or controlled substance; and
(xi) material that directly advertises products to or is intended to attract children under the age of 13.

g. Testimonials & Endorsements:

(i) any testimonials and endorsements contained in advertisements must comply with all applicable law(s), industry codes, rules, and regulations. For example, a clear and conspicuous disclaimer is required if an endorser's results were atypical or if the endorser was paid;
(ii) Erasavir recognizes and maintains a distinct separation between advertising and sponsored content and editorial content. All advertising or sponsored content on the Website of the Company will be clearly and unambiguously identified; and
(iii) a click on an advertisement may only link the User to the website of the Third Party Advertiser(s).

14.COLLECTION, USE, STORAGE AND TRANSFER OF PERSONAL INFORMATION

a. Your profile on the Website is created to store record of Your purchases and Your personal information online.

b. Any information provided or obtained from use of the Services by You becomes part of Your Erasavir record. You agree to provide accurate information to help Us serve You best to Our knowledge, to periodically review such information and to update such information as and when necessary. Erasavir reserves the right to maintain, delete or destroy all communications and materials posted or uploaded to the Website according to its internal record retention and/or destruction policies. You might be contacted via email to review the information provided by You for Erasavir’s record or for the Services. Please make sure You provide a valid email-id and You update it as and when needed. For additional information regarding use of Information about You, please refer to the Privacy Policy.

c.The terms “personal information” and “sensitive personal data or information” are defined under and are reproduced in the Privacy Policy. Please refer to terms therein and the Privacy Policy shall be considered an integral part of these Terms & Conditions.

d.The Users are expected to read and understand the Privacy Policy, so as to ensure that he or she has the knowledge of: the fact that the information is being collected; the purpose for which the information is being collected; the intended recipients of the information; and the various rights available to such Users in respect of such information.

e.Erasavir shall not be responsible in any manner for the authenticity of the personal information or sensitive personal data or information supplied by the Users to the Company or any other person acting on behalf of the Company.

f. The use of the Website involves every Users’ registration information and browsing history being stored and submitted to the appropriate authorities. The consent and procedure for such collection and submission is provided in the Privacy Policy. The other information collected by Erasavir from Users as part of the registration process is described in the Privacy Policy. The consent and revocation procedures in relation to the same are set out in the Privacy Policy.

g.The Users are responsible for maintaining the confidentiality of the Users’ account access information and password. The Users shall be responsible for all uses of the Users’ account and password, whether or not authorized by the Users. The Users shall immediately notify Erasavir of any actual or suspected unauthorized use of the Users’ account or password.

h. If a User provides any information that is untrue, inaccurate, not current or incomplete (or becomes untrue, inaccurate, not current or incomplete), or Erasavir has reasonable grounds to suspect that such information is untrue, inaccurate, not current or incomplete, Erasavir shall have the right to suspend or terminate such account at its sole discretion.

i.By accepting these Terms & Conditions and by registering on the Website, You consent to be contacted by Us and/or by our third party service providers.You further consent to receive Calls, emails and messages (SMS) notifications and information from Us and from Third Party Service Providers including for promotions, discount and/or other service delivery related issues.

15. COVENANTS
(Covenanters for the purposes of these Terms & Conditions shall include the Users and the Third Party Service Providers)

a. Each Covenanter undertakes that it shall not do any act or post, display, upload, modify, publish, transmit, update or share any information that –

(i) belongs to another person and to which the such Covenanter does not have any right;
(ii) is grossly harmful, insulting or harassing on the basis of gender, blasphemous, defamatory, obscene, pornographic, paedophilic, libellous, invasive of another's privacy including bodily privacy, hateful, racially or ethnically objectionable, disparaging, relating or encouraging money laundering or gambling, or otherwise inconsistent with or contrary to the laws in force;
(iii) infringes any patent, trademark, copyright or other proprietary rights;
(iv) violates any law for the time being in force;
(v) impersonates another person;
(vi) is harmful to child;
(vii) deceives or misleads the addressee about the origin of such messages or knowingly and intentionally communicates any information that is patently false or misleading in nature but may reasonably be perceived as a fact;
(viii) contains software viruses or any other computer code, files or programs designed to interrupt, destroy or limit the functionality of any computer resource;
(ix) is prohibited under applicable law(s) for the time being in force; and
(x) is patently false and untrue, and is written or published in any form, with the intent to mislead or harass a person, entity or agency for financial gain or to cause any injury to any person;

b. Erasavir, upon obtaining knowledge by itself or been brought to actual knowledge by an affected person in writing or through email signed with electronic signature about any such information as mentioned in this Clause, shall be entitled to disable such information that is in contravention of this Clause or any provisions of these Terms & Condition. Erasavir shall be entitled to preserve such information and associated records for at least 90 (ninety) days for production to governmental authorities for investigation purposes.

c. In case of non-compliance with any applicable law(s), rules or regulations, or these Terms & Conditions or the Privacy Policy by a Covenanter, Erasavir has the right to immediately terminate the access or usage rights of the Covenanter to the Services and to remove noncompliant information.

16. LIABILITY

a. Erasavir shall not be responsible or liable in any manner to the Users or any Third Party Service Providers (collectively referred to as the “Other Parties”) for any losses, damage, injuries or expenses incurred by Other Parties as a result of any disclosures made by Erasavir, where Other Parties have consented to the making of such disclosures by Erasavir. If the Other Parties had revoked such consent under the terms of the Privacy Policy, then Erasavir shall not be responsible or liable in any manner to the Other Parties for any losses, damage, injuries or expenses incurred by the Other Parties as a result of any disclosures made by Erasavir prior to its actual receipt of such revocation.

b. The Other Parties shall not hold Erasavir responsible or liable in any way for any disclosures by Erasavir under applicable law.

c. The Services provided by Erasavir or any of its licensors or providers or Third Party Service Providers are provided ‘as is’, as available, and without any warranties or conditions (express or implied, including the implied warranties of merchantability, accuracy, fitness for a particular purpose, title and non-infringement, arising by statute or otherwise in law or from a course of dealing or usage or trade). Erasavir does not provide or make any representations, warranties or guarantees, express or implied about the Website or the Services. Erasavir does not verify any content or information provided by the Other Parties on the Website and to the fullest extent permitted by applicable law(s), disclaims all liability arising out of the Other Parties’ use or reliance upon the Website, the Services, the Company Content, Third Party Contents, representations and warranties made by the Other Parties on the Website or any loss arising out of the manner in which the Services have been rendered.

d. The Website may be linked to the website of third parties, affiliates and business partners. Erasavir has no control over, and not liable or responsible for content, accuracy, validity, reliability, quality of such websites or made available by/through the Website. Inclusion of any link on the Website does not imply that Erasavir endorses the linked website. Other Parties may use the links and these services at their own risk.

e. Erasavir shall not be responsible for the mishaps/missed services due to no service/no show from the Other Parties; Erasavir shall not be responsible for any error in any of the services being provided by the Third Party Service Providers.

f. Users accept and acknowledge that Erasavir does not provide any representation or give any guarantee or warranty (whether express or implied, or whether arising by virtue of a statue or otherwise in law or from a course of dealing or usage or trade) in relation to the goods/ products and services made available on its Website by Third Party Service Providers, including any guarantee or warrantee that such goods/ products (i) are merchantable; (ii) fit for the purpose of which they are to be (or have been) purchased;(iii) have accurate description; (iv) do not cause any infringement; and (v) that the Third Party Service Providers have legal title over the goods/products being offered for sale by them on the Website. Erasavir also does not provide any representation or give any guarantee or warranty (whether express or implied) about the Website or any of the Services offered or services offered or provided by the Third Party Service Providers.

g. The Other Parties further accept and acknowledge that Erasavir does not verify any content or information provided by either the Users or the Third Party Services/ or obtained from the Users or the Third Party Service Providers, and to fullest extent permitted by applicable law(s), disclaims all liability arising out of the Other Parties’ use or reliance upon the Website, the Services, the Company Content, Third Party Content, representations and warranties made by the Other Parties on the Website or any opinion or suggestion given or expressed by Erasavir or any Third Party Service Providers in relation to any Services provided by Erasavir.

h. Erasavir assumes no responsibility, and shall not be liable for, any damages to, or viruses that may infect Other Parties’ equipment on account of the Other Parties’ access to, use of, or browsing the Website or the downloading of any material, data, text, images, video content, or audio content from the Website. If any of the Other Party is dissatisfied with the Website, the sole remedy of such Other Party(s) is to discontinue using the Website.

i. The listing of Third Party Service Providers on the Website is based on numerous factors including Users comments and feedbacks. In no event shall the Protected Entities (as defined herein below) be liable or responsible for the listing order of Third Party Service Providers on the Website.

j. To the maximum extent permitted by applicable law(s), Company, its affiliates, independent contractors, service providers, consultants, licensors, agents, and representatives, and each of their respective directors, officers or employees (“Protected Entities”), shall not be liable for any direct, indirect, special, incidental, punitive, exemplary or consequential damages, or any other damages of any kind, arising from, or directly or indirectly related to, (i) the use of, or the inability to use, the Website or the content, materials and functions related thereto; (ii) User's provision of information via the Website; even if such Protected Entity has been advised of the possibility of such damages.

k. In no event shall the Protected Entities be liable for, or in connection with, (i) the provision of, or failure to provide, all or any products or service by a Third Party Service Provider to any User; or (ii) any comments or feedback given by any of the Users in relation to the goods or services provided by any Third Party Service Providers; or (ii) any content posted, transmitted, exchanged or received by or on behalf of any User, Third Party Service Providers or other person on or through the Website.

l. The Users acknowledge that the Protected Entities merely act in the capacity of facilitators between the Other Parties by providing a platform for them to interact and transact. In no event shall the Protected Entities be held liable for any of the losses attributable to Services offered through the Website.

m. In no event shall the total aggregate liability of the Protected Entities to any Other Parties for all damages, losses, and causes of action (whether in contract or tort, including, but not limited to negligence, strict liability, product liability or otherwise) arising from these Terms & Conditions or any Other Parties’ use of the Website exceed an aggregate amount of INR 1000/- (Indian Rupees One Thousand only). Erasavir accepts no liability for any errors or omissions on behalf of the Other Parties.

n. In no event shall the Protected Entities be liable for failure on the part of the Users or Third Party Service Providers to provide agreed services or to make himself/herself available at the appointed time, cancellation or rescheduling of appointments. In no event shall the Protected Entities be liable for any comments or feedback given by any of the Users in relation to the services provided by a Third Party Service Providers.

17. INDEMNITY

The Covenanters agree to defend, indemnify and hold harmless Erasavir, the Protected Entities, independent contractors, service providers, consultants, licensors, agents, and representatives, and each of their respective directors, officers and employees, from and against any and all claims, losses, liability, damages, and/or costs (including, but not limited to, reasonable attorney fees and costs) arising from or related to (a) Covenanters access to or use of Website; (b) Covenanters violation of these Terms & Conditions or any applicable law(s); (c) Covenanters violation of any rights of another person/ entity, including infringement of their intellectual property rights; or (d) Covenanters conduct in connection with the Website.

18. MODIFICATION OF WEBSITE

Erasavir reserves the right to modify or discontinue, temporarily or permanently, the Website or any features or portions thereof without prior notice. Other Parties agree that Erasavir will not be liable for any modification, suspension or discontinuance of the Website or any other part thereof.

19. INTELLECTUAL PROPERTY RIGHTS

All the intellectual property used on the Website except those which have been identified as the intellectual properties of the Other Parties shall remain the exclusive property of the Company. The Other Parties agree not to circumvent, disable or otherwise interfere with security related features of the Website or features that prevent or restrict use or copying of any materials or enforce limitations on use of the Website or the materials therein. The materials on the Website or otherwise may not be modified, copied, reproduced, distributed, republished, downloaded, displayed, sold, compiled, posted or transmitted in any form or by any means, including but not limited to, electronic, mechanical, photocopying, recording or other means.

20. TERMINATION

The provisions of these Terms & Conditions shall continue to apply until terminated by either of the Party as set for below:

a. Erasavir reserves the right to, at any time, and with or without notice, terminate these Terms & Conditions against each of the Users or the Third Party Service Providers or the Other Parties as a whole, if there is:

(i) breach any of applicable law(s), including but not limited to the Captioned Laws or the provisions of these Terms & Conditions or the terms of the Privacy Policy or any other terms, conditions, or policies that may be applicable to the Other Parties from time to time (or have acted in a manner that clearly shows that Other Party(s) do not intend to, or are unable to, comply with the same); or
(ii) Erasavir is unable to verify or authenticate any information provided to Erasavir by Other Party(s); or
(iii) Erasavir believes, in its sole discretion, that Other Party(s) actions may cause legal liability for Erasavir (or any of its affiliates, independent contractors, service providers, consultants, licensors, agents, and representatives) or are contrary to the interests of the Website; or (iv) Erasavir is required to do so by law; or
(v) if Other Party(s) fail to provide (or after providing such consent, later revoke) the consents necessary or desirable for Erasavir to provide the Services to the Other Party(s); or
(vi) The provision of the Services to the Other Party(s), or to the general public, is in Erasavir’s opinion, no longer commercially viable; or
(vii) Erasavir has elected to discontinue, with or without reason, access to the Website or the Services (or any part thereof).

b. Erasavir may also terminate or suspend (temporarily or permanently) all or a portion of Other Party(s) account or access to the Services, with or without reason. Except as may be set forth in any of the terms applicable to a particular Service, termination of Other Party(s) account may include: (i) removal of access to all offerings within the Website or with respect to the Services; and (ii) barring Other Party(s) from further use or access of the Website or of any of the Services.

c. Once terminated or suspended (temporarily or permanently), Other Party(s) may not continue to use the Website under the same account, a different account or re-register under a new account.

d. Upon termination of these Terms & Conditions, Erasavir shall have no obligation to maintain or provide any of Other Party(s) data and may thereafter, unless legally prohibited, delete all of Other Party(s) data in its systems or otherwise in its possession or under its control, including but not limited to Other Party(s) personal information, log-in ID and password, order details (including any prescriptions uploaded) and all related information, files and materials associated with or inside Other Party(s) account (or any part thereof).

e. Erasavir reserves the right, at its sole discretion, to pursue all of its legal remedies, including but not limited to deletion of the Other Party(s) content from the Website with or without ability to access the Website and the other Services, upon any breach by the Other Party(s) of these Terms & Conditions or if Erasavir is unable to verify or authenticate any information the Other Party(s) submits to Erasavir, or if the Other Party(s) fail to provide (or after providing such consent, later revokes) the consents necessary or desirable for Erasavir to provide the Services to the Other Party(s).

f. The right to terminate/ suspend the account is in addition to, and without prejudice to, Erasavir’s right to initiate action against the Other Party(s), in accordance with applicable law.

21. FORCE MAJEURE

Other Parties accept and acknowledge that Erasavir shall not be liable for any loss or damage caused to the User as a result of delay or default or deficiency or failure in the Services as a result of any natural disasters, fire, riots, civil disturbances, actions or decrees of governmental bodies, communication line failures (which are not caused due to the fault of Erasavir or the Third Party Service Providers), or any other delay or default or deficiency or failure which arises from causes beyond Erasavir’s reasonable control (“Force Majeure Event”). In the event of any Force Majeure Event arising, Erasavir, depending on whose performance has been impacted under the Terms & Conditions, shall immediately give notice to the Other Party(s) of the facts which constitute the Force Majeure Event.

22. GOVERNING LAW AND DISPUTE RESOLUTION

These Terms & Conditions shall be governed by, and construed in accordance with, the laws of the Commonwealth of Pennsylvania without reference to conflict of laws principles.

23. SURVIVAL

Even after termination, certain obligations mentioned under Covenants, Liability, Indemnity, Intellectual Property, Dispute Resolution will continue and survive termination.

24. SEVERABILITY

If any provision of these Terms & Conditions is deemed invalid, unlawful, void or for any other reason unenforceable, then that provision shall be deemed severable from these Terms & Conditions and shall not affect the validity and enforceability of any of the remaining provisions.

25. WAIVER

No provision of these Terms & Conditions shall be deemed to be waived and no breach excused, unless such waiver or consent shall be in writing and signed by Erasavir. Any consent by Erasavir to, or a waiver by Erasavir of any breach by Other Parties, whether expressed or implied, shall not constitute consent to, waiver of, or excuse for any other different or subsequent breach.

26. HEADINGS

The headings and subheadings herein are included for convenience and identification only and are not intended to describe, interpret, define or limit the scope, extent or intent of these Terms & Conditions.

27. CONTACT INFORMATION

If any Other Party(s) has any grievance, comment, question or suggestion regarding any of our Services, please contact our customer service at [hello@erasavir.com]. If any Other Party(s) has any questions concerning Erasavir, the Website, these Terms & Conditions, or anything related to any of the foregoing, Erasavir can be reached at the following email address – [hello@erasavir.com] or via the contact information available from the following: Contact Us.

My account

Login

Lost your password?

Create an account?

Darpan Roy Chowdhury


Darpan Roy Chowdhury

Darpan is committed to exploring innovative areas in healthcare, and finding solutions which can make a difference. He is driven by a desire to create value in the Indian healthcare landscape. He co-founded ErasaVir amidst the pandemic, as he wanted to help the world return to an uninterrupted life. He is on a mission to serve as many people around the globe as possible, with a safe and easy protective solution. He is our go-to person for clearing hurdles and steering through icebergs to achieve the lofty goals imagined by the ErasaVir team.
Darpan also leads business development at Strassenburg Pharmaceuticals. His experiences have ranged from the pharmaceutical manufacturing and marketing sectors, to startups working on new technologies and services – including telemedicine, patient outcomes in healthcare and after-school education.According to him, solutions of any kind (especially in healthcare) must be empathetic to the realities of those they serve. ErasaVir to him represents a step in the right direction-a way to preserve our way of life and reduce the suffering of people worldwide.

This will close in 0 seconds

Dr. Dino Rotondo


Dr. Dino Rotondo

Dr. Rotondo serves as Senior Lecturer in Immunology, Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS),University of Strathclyde, Glasgow UK. During his scientific career he has carried out extensive research on polyunsaturated fatty acids (PUFAs) – particularly in the domain of molecular and cellular mechanisms related to immune function. He has published key research papers on PUFAs and eicosanoid metabolites’ effects on cell function. Dr. Rotondo’s early research work on dexamethasone (1987), demonstrated its systemic anti-inflammatory actions in response to double-stranded RNA mimicking viral activation. This has now become centre-stage in the use of dexamethasone (abreakthrough drug) in thetreatment of Covid-19 hyperinflammation.
Dr. Rotondo serves as CSO at ErasaVir. He is responsible for the scientific rationale which forms the backbone of our platform, and leads our research efforts. He firmly believes that those who have the requisite knowledge to make a difference also have a great responsibility towards humanity – his commitment to ErasaVir is inspired by this belief.

This will close in 0 seconds

Dr. Kumaril Bhargava


Dr. Kumaril Bhargava

Dr. Kumar Bhargava is currently serving as a Chief Executive Officer at Serentrix Therapeutics, a specialty company with focus on ocular pain. Prior to Serentrix; Dr. Bhargava led the Strategic Innovation in External Research & Development Innovation group at Pfizer from 2009 – 2011. He has more than twenty years of experience in drug development and business expansion gained at Abbott Labs, American Pharmaceutical Partners, Procter & Gamble and Johnson and Johnson.Dr. Bhargava received the Chairman’s award given to selected employees for their distinguished performance at Abbott labs.
Dr. Bhargava leads activities related to product development for us. He is driven by the belief that innovations in drug development can radically improve health outcomes across the world.

This will close in 0 seconds

Dr. Vijay Tammara


Dr. Vijay Tammara

Dr. Tammara’s regulatory expertise spans both oral and injectable dosage forms of small molecules, peptides, proteins, monoclonal antibodies and vaccines. He also serves as Sefacor Inc’s Head of Regulatory Affairs – guiding them through the complex regulatory process pertaining to oncology drugs. Dr. Tammara has over 20 years of leadership experience in the field of global regulatory affairs, strategic drug development, and clinical strategy. He has made significant contributions to the approval of several products during his positions of leadership at biotech and large pharmaceutical companies, which includes serving as VP Regulatory Affairs at Frontage Labs and Nuron Biotech Inc., Director Regulatory Affairs at Merck & Co., Inc., Senior Associate Director at Wyeth Pharmaceuticals, and Assistant Director at Sanofi-Synthelabo in Worldwide Regulatory Affairs.
Prior to his industrial experience, he held positions of increasing responsibility in the Office of Clinical Pharmacology and Biopharmaceutics at the US FDA and received several FDA awards for excellence. Dr. Tammara advises us on all regulatory affairs and is committed to ensuring that people all around the world can benefit from ErasaVir’s unique properties.

This will close in 0 seconds

Soumitra Sen


Soumitra Sen

We call Soumitra ‘The Thinker’, as he has shaped his life thinking about innovative brands. He has spent more than 30 years in the advertising industry launching & building consumer brands like Becosules, Gelusil, Nasivion, Nise Gel, Calcium Sandoz, One Touch, Seven Seas etc. FMCG brands that he particularly takes pride in being associated with are Cinthol, Good Knight and Amul.
He has now dedicated himself to ensuring that the world gets back the power and the urge to lead an ‘uninterrupted life’ with the protective acumen of ErasaVir. Soumitra loves his books and is passionate about watching sports sans the ones that promote violence. He pursues the life story of his only daughter who is settled in Sydney by being in touch daily with her via Facetime, WhatsApp Video or Duo.

This will close in 0 seconds

Urvashi Guha


Urvashi Guha

Urvashi has been the quintessential creator all her life. She is forever in the quest of launching brands with innovative stories that touch the heart, mind and soul of the consumer. She has demonstrated this acumen in the past 25 years with brands like Becosules, Gelusil, Nasivion, Seven Seas, Calcium Sandoz, Botox, Juvederm, Philips, Becton Dickinson and others.
Her next milestone is to provide ErasaVir with the equity of an uninterrupted life that is trusted by consumers worldwide. In her spare time one can find her tending to the beautiful plants in her garden, dabbling with art, reading books and being a friend to her two talented daughters who are young women in their own right.

This will close in 0 seconds

Disha Roy Chowdhury


Disha Roy Chowdhury

Disha is a legal professional with experience in IP and civil Law. However, today she focuses on working with consumer products which seek to make a difference. Previously she served in the trademarks department at DP Ahuja, a reputed Intellectual property firm in Kolkata. Following this she was on the legal team at IJM (International Justice Mission) – an NGO that specialises in combatting issues of sex trafficking and child labour. Having a keen interest in people, she always sought roles where she could contribute to society in a meaningful way. During the second wave of the pandemic in India,Disha founded EasyMeds to help patients gain access to Covid-19 medications.
Her true passion, she says, lies in creating products and services that give people the opportunity to choose better. In a world of countless options, she aims to help brands with a difference communicate themselves to the consumer. At ErasaVir she is determined to create meaningful conversations with the global community, in order to inform and educate them in these trying times.

This will close in 0 seconds

Reva Mann


Reva Mann

Reva has almost a decade of experience in corporate legal affairs, and business management. After graduating from law school, Reva spent time at the Centre for Law and Policy Research followed by the United Nations Mechanism for International Criminal Tribunals (UN-MICT), before moving on to Shardul Amarchand Mangaldas as an associate. In addition, she serves as Managing Partner at J.S. Automobiles – a leading automobile distributor in northern India.
Reva brings with her a deep sensibility with respect to ‘Intellectual Property’ and ‘International Business Law’
considerations. Convinced that ErasaVir can make life better for a large number of consumers worldwide, she joined us to address all legal and operational concerns. Very soon, she will be traveling to the US in order to complete her LLM at Columbia University, New York.

This will close in 0 seconds

Deepnath Roy Chowdhury


Deepnath Roy Chowdhury

Deepnath has over 35 years of leadership experience in the Indian pharmaceutical industry. Having founded Strassenburg Pharmaceuticals in 1985, he has since gone on to build the organisation into a respected name in the country’s ethical pharmaceutical marketing sector. Under his aegis, Strassenburg has won several accolades for innovation, financial performance, employee satisfaction and contributions to society. Deepnath is also the immediate past president of the Indian Drug Manufacturer’s Association, and has a wealth of experience in liaising between corporate and governmental bodies. He strongly believes in India’s capabilities to provide the world with affordable, high-quality medication, and advises us on our manufacturing and marketing activities in the country.

This will close in 0 seconds

Hari Menon


Hari Menon

Hari Menon is the CEO of Bigbasket.com, a company he co-founded in December 2011 with a vision of setting up India’s finest online groceries delivery platform. Bigbasket, India’s largest online supermarket, delivers the entire range of groceries and a wide range of household products in 40 cities in India working closely with 30,000 farmers. It delivers more than 4,00,000 orders per day to 15 million customers, relying on a team of 29,000 people.
Hari and Bigbasket are recipients of prominent awards, namely – Consumer Internet Company of the Year by VC Circle Awards 2016; Ranked 4th by YourStory in the Top 100 Indian startups with gravity defying momentum in 2015; Best Startup of the year in 2014 by Bangalore Management Association; Best Online Grocer at the Coca Cola Golden Spoon Awards 2016; First runner up (Silver) at the Global eCommerce Summit Awards held in Barcelona; Best Retail and eCommerce App of the Year at the AWS Mobility Awards 2017; Rated the Top Brand in the Forrester’s India Customer Experience Index 2016. To his independent credit, Hari has been awarded for entrepreneurship by the Indira Group of Institutions; AUDI-RITZ ICON AWARDS from RITZ lifestyle magazine in the category of Entrepreneurship and “Champion of Tomorrow” by CEO INDIA Magazine. He is a regular speaker at most major retail and e-commerce forums/events in India.
With his vast and deep experience; Hari will be invaluable as he advises and guides Palani LLC and the ErasaVir brand to best serve customers globally. His strategic and operational insights will be indispensable to Palani LLC and ErasaVir.

This will close in 0 seconds

Dr. RBN Prasad


Dr. RBN Prasad

Dr. RBN Prasad was the former Chief Scientist and Head of the Centre for Lipid Research at CSIR-Indian Institute of Chemical Technology, Hyderabad. Dr Prasad is a highly distinguished lipid scientist and made outstanding contributions in areas of lipid chemistry and technology for over 45 years. Dr Prasad’s research contributions were aimed at the modernization of vegetable oils, oleochemicals and allied products industry in India, leading to operational efficiency, cost reduction and environmental sustainability.
His contributions were also significant in the basic research related to polyunsaturated fatty acids, surfactants, biolubricants, enzymatic modifications of lipids etc. Dr Prasad has over 275 original research papers in reputed scientific journals, 22 book chapters and 71 Indian and international patents to his credit. In addition he has overseen the transfer of technologies to several industries. Dr Prasad was the recipient of 20 prestigious National awards like CSIR Technology Prize, Technology Development Board’s Best Indigenous Technology, Vasvik Award, Industrial Green Chemistry Award of Green Chemistry Network Centre of ACS etc. Dr Prasad was the National President of Oil Technologists’ Association of India and Association of Food Scientist & Technologists (India). Dr Prasad is also part of several expert committees of Govt. Funding Agencies and Food Regulatory Agencies.
Dr Prasad is providing guidance to the Erasavir Team for the activities related to product development and manufacturing as a scientific advisor.

This will close in 0 seconds

Dr. Suman Kapur


Dr. Suman Kapur

Dr. Kapur presently serves as Senior Professor, Department of Biological Sciences at the Birla Institute of Technology & Science, Pilani (Hyderabad Campus). Her research interests include ‘Genetic markers for vulnerability to chronic human diseases’, ‘Medical devices for field deployment in low resource settings’, and ‘Prevention of diseases through natural products’ among others. Dr. Kapur has a wealth of experience in the field, having authored over 200 published journal articles spanning across a wide range of subjects. She also serves on the boards and governing bodies of multiple Indian and overseas educational and research institutions.
Having created proprietary formulations and devices serving a variety of objectives, Dr. Kapur has brought her research and practical experience to the ErasaVir team, furthering our formulation, efficacy, and general research objectives.

This will close in 0 seconds

Lalit Ambastha


Lalit Ambastha

Lalit is an IP Attorney with more than 14 years of experience in the field of Intellectual Property. Post gaining learning experience during his association with leading IP Law firms, Lalit founded Patentwire, a Patent and Technology Consulting firm, in 2008. Lalit is empanelled as speaker and faculty with Ministry of MSME, Govt. of India, for IP Awareness Programmes organized by the Ministry. He is also empanelled as IP Consultant with Ministry of Skill Development and Entrepreneurship, Government of India.
Lalit has dealt with patents across all major fields of invention for Indian and Overseas Clients including DMRC, Honda, IITs, Novartis, Viber, DBT, and ICAR. His experience is spread across sectors like General Utility, Chemical, Medical, Immunological, Biochemical, Herbal, Agriculture, Biotechnological, Pharmaceuticals, Mechanicals, IT, and Electronics. At ErasaVir, Lalit leads our IP objectives and advises us on all things legal.

This will close in 0 seconds

Anupam Dokeniya


Anupam Dokeniya

Anupam has accumulated entrepreneurial experience in a variety of sectors, but sees innovation in life sciences as his true passion. For over 15 years, he has been working in oncology with fatty acids-this formed the basis of ErasaVir’s ideation. Convinced that there are healthcare solutions which can give hope to humanity during this difficult time, Anupam begun the process of building a collective of scientists and entrepreneurs to sculpt this idea into reality.
Prior to ErasaVir, the devastation caused by cancer had moved Anupam on a deeper level. This led him to form Sefacor – to make a positive difference in the lives of patients (and their loved ones) suffering from deadly tumors, starting with high grade glioma, including GBM (Glioblastoma Multiforme). Before entering the healthcare domain Anupam spent time at Santander Investments, Strategic Capital Management, and The World Bank, in addition to founding NSA Investments and Indus Partners. Anupam’s audacious dream is to regularly serve a billion people by providing them an additional layer of safety with ErasaVir and its subsequent versions.

This will close in 0 seconds

CB Bhattacharya


Dr. CB Bhattacharya

CB Bhattacharya is the H.J. Zoffer Chair in Sustainability and Ethics at the Katz Graduate School of Business, University of Pittsburgh. He is a world-renowned expert in business strategy innovation aimed at increasing both business and social value. His research and teaching focus specifically on how companies can use underleveraged “intangible assets” such as corporate identity, reputation, corporate social responsibility and sustainability to strengthen stakeholder relationships and drive firm market value.
Prof. Bhattacharya has published over 100 articles and has over 37,000 citations per Google Scholar, placing him among the top 50 cited marketing academics per Google Scholar and the top 1% of marketing academics per a Stanford University study. His latest book entitled Small Actions Big Difference: Leveraging Corporate Sustainability to Drive Business and Societal Value was published by Routledge in 2019. He is co-author of the book Leveraging Corporate Responsibility: The Stakeholder Route to Maximizing Business and Social Value and co-editor of the book Global Challenges in Responsible Business, both published by Cambridge University Press.
Prof. Bhattacharya is part of a select group of faculty members that have been named twice to Business Week’s Outstanding Faculty list. He is on the #thinklist of the University of Bath, a list of influential faculty thinkers on issues of responsible business He has won several best paper awards, teaching awards and research prizes. He was also a finalist for the Aspen Institute’s Faculty Pioneer Award in 2007. In addition, he received the Emory Williams Distinguished Teaching Award in 1995, the highest teaching award at Emory University.
Prof. Bhattacharya has conducted research and consulted for many organizations such as Allianz, AT&T, Bosch, Eli Lilly, E.ON, General Mills, Green Mountain Coffee, High Museum of Art, Hitachi Corporation, Procter & Gamble Company, Prudential Bank, Timberland and Unilever.

This will close in 0 seconds